Harrow Health Inc (HROW)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Mark L. Baum
Employees:
180
12264 EL CAMINO REAL, SUITE 350, SAN DIEGO, CA 92130
858-704-4040

Harrow Health, Inc. owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of therapeutics for ocular surface diseases.

Data derived from most recent annual or quarterly report
Market Cap 326.923 Million Shares Outstanding35.115 Million Avg 30-day Volume 1.01 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.24
Price to Revenue4.3116 Debt to Equity2.5159 EBITDA19.423 Million
Price to Book Value6.4977 Operating Margin3.0902 Enterprise Value607.723 Million
Current Ratio5.795 EPS Growth0 Quick Ratio4.853
1 Yr BETA 0.6153 52-week High/Low 28.25 / 7.6 Profit Margin-12.4449
Operating Cash Flow Growth-318.1818 Free Cash Flow to Firm (FCFF) TTM -158.657 Million Free Cash Flow to Equity (FCFE) TTM226.224 Million
Altman Z-Score1.6477
View SEC Filings from HROW instead.

View recent insider trading info

Harrow Health Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding HROW (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding HROW

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-11-16 by OPALEYE MANAGEMENT INC.
  • 4: filed on 2023-11-14 by SAHAREK JOHN P.
  • 4: filed on 2023-09-20 by OPALEYE MANAGEMENT INC.
  • 4: filed on 2023-08-15 by MAKARY MARTIN A.
  • 4: filed on 2023-07-20 by SAHAREK JOHN P.
  • 4: filed on 2023-07-20 by BOLL ANDREW R.
  • 4: filed on 2023-06-23 by VAN HORN R. LAWRENCE
  • 4: filed on 2023-06-23 by STERNBERG PERRY J.
  • 4: filed on 2023-06-23 by MAKARY MARTIN A.
  • 4: filed on 2023-04-04 by BAUM MARK L

    • Events (8k)

  • 8-K: filed on 2023-11-13:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-11-03:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-09-29:
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-08-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-07-21:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-07-18:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-23:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2023-05-11:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-28:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 1.02: Termination of a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-23:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    32.5 Thousand total shares from 2 transactions

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    20 Thousand total shares from 1 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    BAUM MARK L CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 2,022,961 2023-11-16 6

    SAHAREK JOHN P. CHIEF COMMERCIAL OFFICER

    • Officer
    		 232,419 2023-11-10 3

    OPALEYE MANAGEMENT INC.

    • 10% Owner
    		 3,620,000 2023-09-19 3

    MAKARY MARTIN A.

    • Director
    		 45,000 2023-08-14 3

    BOLL ANDREW R. CHIEF FINANCIAL OFFICER

    • Officer
    		 534,169 2023-07-18 4

    VAN HORN R. LAWRENCE

    • Director
    		 0 2023-06-21 2

    SPARKS TERESA

    • Director
    		 0 2023-06-21 1

    STERNBERG PERRY J.

    • Director
    		 0 2023-06-21 1

    LINDSTROM RICHARD L MD

    • Director
    		 126,100 2022-09-30 0

    KAMMER ROBERT J

    • Director
    		 9,644 2021-06-25 0

    PRINCIPI ANTHONY

    • Director
    		 93,798 2020-09-28 0

    AUSTIN STEPHEN G

    • Director
    		 91,987 2020-03-16 0

    LONGBOARD CAPITAL ADVISORS, LLC

    CONRAD BRETT

    • INSTITUTIONAL INVESTORMANAGING MBR OF LONGBOARD CAP.
    		 1,416,000 2017-12-31 0

    EDWARDS CLAYTON D CHIEF OPERATING OFFICER

    • Officer
    		 0 2017-04-13 0

    NELSON WILLIAM H.

    • Director
    		 0 2016-06-10 0

    MILONI DONALD PAUL

    • 10% Owner
    		 No longer subject to file 2015-05-18 0

    BASSANI AUGUST SHELBY

    • Director
    		 13,488 2014-09-04 0

    KENNY PETER C

    • Director
    		 0 2013-10-02 0

    ABRAMS JEFFREY J

    • Director
    		 45,927 2013-06-27 0

    FINNEGAN PAUL

    • Director
    		 6,865 2013-06-27 0

    SCHUPP JOACHIM PH CHIEF MEDICAL OFFICER

    • Officer
    		 0 2013-04-01 0

    PROFESSIONAL COMPOUNDING CENTERS OF AMERICA, INC.

    • 10% Owner
    		 832,682 2012-08-31 0

    DERMASTAR INTERNATIONAL, LLC

    • 10% Owner
    		 0 2012-06-29 0

    LADONNIKOV ALEXEJ

    • 10% Owner
    		 1,984,156 2012-02-28 0

    BRAR BALBIR

    • Director
    		 66,022 2012-01-23 0

    BONFIGLIO JOHN N PRESIDENT AND CEO

    • Officer
    • Director
    		 0 2010-10-20 0

    NIDA TERRY CHIEF BUSINESS OFFICER

    • Officer
    		 0 2010-02-26 0

    LOMORO JOHN T CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2009-06-18 0

    SINGH JULIET CEO, DIRECTOR AND PRESIDENT

    • Officer
    • Director
    • 10% Owner
    		 0 2009-06-18 0

    THORNLEY ANTHONY S

    • Director
    		 0 2008-11-21 0

    SWANN LYNN C

    • Director
    		 0 2008-11-21 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    BAUM MARK L - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-11-16 16:45:11 -0500 2023-11-16 P 7,500 $8.11 a 2,022,961 direct 5.5804 1.5625 5.5804 2 0.0 1

    OPALEYE MANAGEMENT INC. - > 10% Owner by opaleye, l.p.

    		2023-11-16 16:05:31 -0500 2023-11-15 P 25,000 $8.03 a 3,645,000 indirect 5.5804 1.5625 5.5804 2 0.0 1

    SAHAREK JOHN P. - Officer CHIEF COMMERCIAL OFFICER

    		2023-11-14 19:02:22 -0500 2023-11-10 F 9,778 $12.83 d 232,419 direct 6.1728 13.4568 16.7901 4 0.0 1

    SAHAREK JOHN P. - Officer CHIEF COMMERCIAL OFFICER

    		2023-11-14 19:02:22 -0500 2023-11-10 M 20,000 a 242,197 direct 6.1728 13.4568 16.7901 4 0.0 1

    SAHAREK JOHN P. - Officer CHIEF COMMERCIAL OFFICER

    		2023-11-14 19:02:22 -0500 2023-11-10 M 20,000 d 0 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    HARROW INC HROW 2023-12-01 22:15:04 UTC 4.7814 0.5386 2800000
    HARROW INC HROW 2023-12-01 21:45:05 UTC 4.7814 0.5386 2800000
    HARROW INC HROW 2023-12-01 21:15:04 UTC 4.7814 0.5386 2800000
    HARROW INC HROW 2023-12-01 20:45:04 UTC 4.7814 0.5386 2800000
    HARROW INC HROW 2023-12-01 20:15:04 UTC 4.7814 0.5386 2800000
    HARROW INC HROW 2023-12-01 19:45:04 UTC 4.7814 0.5386 2800000
    HARROW INC HROW 2023-12-01 19:15:04 UTC 4.7814 0.5386 2800000
    HARROW INC HROW 2023-12-01 18:45:05 UTC 4.7814 0.5386 2800000
    HARROW INC HROW 2023-12-01 18:15:03 UTC 4.7814 0.5386 2800000
    HARROW INC HROW 2023-12-01 17:45:04 UTC 4.7814 0.5386 2800000
    HARROW INC HROW 2023-12-01 17:15:03 UTC 4.7814 0.5386 2800000
    HARROW INC HROW 2023-12-01 16:45:03 UTC 4.7772 0.5428 2800000
    HARROW INC HROW 2023-12-01 16:15:04 UTC 4.7772 0.5428 2800000
    HARROW INC HROW 2023-12-01 15:45:03 UTC 4.7772 0.5428 2800000
    HARROW INC HROW 2023-12-01 15:15:05 UTC 4.7772 0.5428 2700000
    HARROW INC HROW 2023-12-01 14:45:03 UTC 4.721 0.599 2700000
    HARROW INC HROW 2023-12-01 14:15:04 UTC 4.721 0.599 2700000
    HARROW INC HROW 2023-12-01 13:45:04 UTC 4.7981 0.5219 2700000
    HARROW INC HROW 2023-12-01 13:15:04 UTC 4.7981 0.5219 2700000
    HARROW INC HROW 2023-12-01 12:45:04 UTC 4.7981 0.5219 2700000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    VANGUARD MONTGOMERY FUNDS- VANGUARD MARKET NEUTRAL FUND HROW -104917.0 shares, $-1507657.29 2023-09-30 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments